Majority of Americans fear they will lose their job in the next six months: study

Remdesivir Can’t Cure Covid, But Good Luck Telling Gilead Stock

Gilead Sciences (NASDAQ:GILD) created Remdesivir to treat the Ebola virus. This is a coronavirus similar to, though not precisely like, the COVID-19 strain behind the global pandemic.Source: Eyesonmilan / Shutterstock.com Now, having teased the drug's results through fast trials that would usually be classed as preliminary, Gilead says it's ready to profit.Once donated supplies of 1.5 million doses are exhausted, probably in June, the company will start charging. Based on "Quality Adjusted Life Years," the idea that drugs should be priced based on the value of a life, a price of $4,340 per treatment has been suggested.InvestorPlace - Stock Market News, Stock Advice & Trading TipsGilead sees a "multi-year commercial opportunity" in remdesivir, but the price of GILD stock has fallen over the past month. It opened May 22 at about $73/share, indicating a market cap of $92 billion on pre-Remdesivir revenues of $22.7 billion. The Remdesivir TrialGilead was a profit...

Oppenheimer Bullish On Wireless Services, Upgrades American Tower, Crown Castle

While the coronavirus has caused uncertainty and sparked recessionary fears, temporarily slowing new network builds, tower growth appears set to reaccelerate, according to Oppenheimer.The American Tower, Crown Castle Analyst Timothy Horan upgraded American Tower Corp (NYSE: AMT) and Crown Castle International Corp (NYSE: CCI) from Perform to Outperform and set price targets of $270 and $175, respectively.The American Tower, Crown Castle Thesis American Tower and Crown Castle are both witnessing strong and accelerating demand from carriers, with mobile broadband becoming more important than ever, Horan said in the Friday upgrade note. (See his track record here.)The analyst expects a solid rebound in tower activity from T-Mobile US, Inc. (NASDAQ: TMUS) this year, buildouts by DISH Network Corp (NASDAQ: DISH), strong spend by Verizon Communications Inc. (NYSE: VZ) and rural fixed wireless boosted by government subsidies.Massive spectrum auctions scheduled for the back half of 2020 are also positives, he said.Oppenheimer projects that...

7 Inexpensive, High-Dividend ETFs to Buy

[Editor's note: "7 Inexpensive, High-Dividend ETFs to Buy" was previously published in January 2020. It has since been updated to include the most relevant information available.]The universe of exchange-traded funds (ETFs) is awash in low-fee products, and the space is growing as issuers reduce their fees to lure investors.Income-seeking investors do not have to pay up to access high-dividend ETFs. In fact, numerous high-dividend ETFs can be inexpensive, which is an important point for income investors looking to keep more of those dividends and a higher share of their invested capital.InvestorPlace - Stock Market News, Stock Advice & Trading TipsHigh-dividend ETFs are often embraced by long-term investors and over the long-term, lower fees can mean better outcomes for investors. * 7 Excellent Penny Stocks Ready to Roar Over the past several years, data confirm that when it comes to adding new assets, the best ETFs are usually those with annual fees...